Judge Allows Pradaxa Lawsuits To Proceed Directly To Federal Court
5 November 2012No Comments
Just last month, the Journal for the American Medical Association warned consumers and medical professionals that the FDA may have rushed into its approval of the blood thinner Pradaxa, overlooking critical risks like early trials indicating that there was no reversal agent for internal bleeding side effects potentially associated with Pradaxa. The warning comes on the heels of an FDA notice issued in December 2011, in which the agency revealed that it was investigating Pradaxa in light of a higher-than-expected rate of Pradaxa injury and death reports. As of August 2012, data showed that the FDA had received 3,781 reports of side effects and 542 reports of deaths among patients using Pradaxa in 2011 – putting Pradaxa ahead of all other medications for injury and death reports that year. If you took the anticoagulant Pradaxa, and you have since experienced a major side effect like internal bleeding, contact our experienced Pradaxa lawyers at Bandas Law Firm immediately to discuss your legal options.
Injuries And Deaths Potentially Linked To Pradaxa
Pradaxa is a popular blood thinner, commonly prescribed to prevent blood clots and stroke in patients diagnosed with atrial fibrillation. Pradaxa is one of the first anticoagulants to rival warfarin, a hugely successful blood thinner that has been on the market for nearly 60 years, and Pradaxa maker Boehringer Ingelheim has promoted the drug as superior to other anticoagulants. The major difference between warfarin and Pradaxa though, is that there is no antidote for internal bleeding side effects caused by Pradaxa. For patients who suffer excessive bleeding related to warfarin treatment, Vitamin K can be administered to reverse the effects of the drug. Unfortunately, many Pradaxa patients have died since the drug’s introduction in October 2010, because doctors were helpless against internal bleeding complications.
Pradaxa Lawsuits Consolidated In Federal MDL
In light of the growing number of Pradaxa lawsuits filed against Boehringer Ingelheim, a federal judge overseeing Pradaxa lawsuits filed on behalf of affected patients has entered an order in an effort to expedite the the claim filing process. On October 4, 2012, Judge David Herndon filed a Case Management Order, allowing for direct filing of claims into the Pradaxa federal MDL, or multidistrict litigation. Due to the large number of Pradaxa lawsuits expected to be filed by affected individuals, a central court has been established in Illinois to handle the side effect claims. As of September 5, 2012, the U.S. Judicial Panel on Multidistrict Litigation indicated that more than 100 Pradaxa claims had already been filed against Boehringer Ingelheim, whose attempts to dismiss Pradaxa bleeding lawsuits were denied by Judge Herndon in July 2012.
Our Qualified Pradaxa Attorneys Can Help
With mounting litigation associated with potential Pradaxa bleeding side effects, patients who believe they may have been adversely affected by the blood thinner are urged to consult an experienced Pradaxa lawyer immediately. Here at Bandas Law Firm, our defective drug attorneys have extensive experience protecting the legal rights of patients affected by dangerous medications, and will work diligently to help victims of alleged Pradaxa side effects pursue the compensation they are entitled to. If you took Pradaxa and have since suffered internal bleeding side effects, or if you lost a loved one to potential Pradaxa complications, contact our knowledgeable Pradaxa attorneys at Bandas Law Firm today.